The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994
Open accessAbstract
OBJECTIVE: To estimate the fall in coronary heart disease (CHD) mortality in Scotland attributable to medical and surgical treatments, and risk factor changes, between 1975 and 1994. DESIGN: A cohort model combining effectiveness data from meta-analyses with information on treatment uptake in all patient categories in Scotland. SETTING AND PATIENTS: The whole Scottish population of 5.1 million, including all patients with recognised CHD. INTERVENTIONS: All cardiological, medical, and surgical treatments, and all risk factor changes between 1975 and 1994. Data were obtained from epidemiological surveys, routine National Health Service sources, and local audits. MAIN OUTCOME MEASURES: Deaths from CHD in 1975 and 1994. RESULTS: There were 15 234 deaths from CHD in 1994, 6205 fewer deaths than expected if there had been no decline from 1975 mortality rates. In 1994, the total number of deaths prevented or postponed by all treatments and risk factor reductions was estimated at 6747 (minimum 4790, maximum 10 695). Forty per cent of this benefit was attributed to treatments (initial treatments for acute myocardial infarction 10%, treatments for hypertension 9%, for secondary prevention 8%, for heart failure 8%, aspirin for angina 2%, coronary artery bypass grafting surgery 2%, and angioplasty 0.1%). Fifty one per cent of the reduction in deaths was attributed to measurable risk factor reductions (smoking 36%, cholesterol 6%, secular fall in blood pressure 6%, and changes in deprivation 3%). Other, unquantified factors apparently accounted for the remaining 9%. These proportions remained relatively consistent across a wide range of assumptions and estimates in a sensitivity analysis. CONCLUSIONS: Medical treatments and risk factor changes apparently prevented or postponed about 6750 coronary deaths in Scotland in 1994. Modest gains from individual treatments produced a large cumulative survival benefit. Reductions in major risk factors explained about half the fall in coronary mortality, emphasising the importance and future potential of prevention strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Self-citationBlood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,645
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · Cited by 3,322
Antiplatelet Trialists' Collaboration (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 3,126
Fibrinolytic Therapy Trialists' (FTT) Collaborative Group (1994) · The Lancet · doi:10.1016/s0140-6736(94)91161-4 · Cited by 2,744
Yusuf, S., Zucker, D., Passamani, E., Peduzzi, P., Takaro, T., Fisher, L. D., Kennedy, J. W., Davis, K., Killip, T., Norris, R., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91963-1 · Cited by 2,134
Garg, R. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520420066040 · Cited by 1,771
Tuomilehto, J., Vidgren, G., Toivanen, L., Tuomilehto-Wolf, E., Kohtamaki, K., Stengård, J., Zimmet, P., Mackay, I. R., Rowley, M., & Koskela, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92521-6 · Cited by 1,692
Law, M. R., Wald, N. J., & Thompson, S. G. (1994) · BMJ · doi:10.1136/bmj.308.6925.367 · Cited by 1,210
Cumulative Meta-Analysis of Therapeutic Trials for Myocardial Infarction
Lau, J., Antman, E. M., Jimenez-Silva, J., Kupelnick, B., Mosteller, F., & Chalmers, T. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207233270406 · Cited by 1,140
Recent Trends in Acute Coronary Heart Disease — Mortality, Morbidity, Medical Care, and Risk Factors
McGovern, P. G., Pankow, J. S., Shahar, E., Doliszny, K. M., Folsom, A. R., Blackburn, H., & Luepker, R. V. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604043341403 · Cited by 699
Hunink, M. G. M. (1997) · JAMA · doi:10.1001/jama.277.7.535 · Cited by 679
Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population
McDonagh, T. A., Morrison, C. E., Lawrence, A., Ford, I., Tunstall-Pedoe, H., McMurray, J. J., & Dargie, H. J. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03033-x · Cited by 630
Self-citationMeta-analysis of randomised trials comparing coronary angioplasty with bypass surgery
Pocock, S. J., Henderson, R. A., Rickards, A. F., Hampton, J. R., King, S. B., Hamm, C. W., Puel, J., Hueb, W., Goy, J.-J., & Rodriguez, A. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92897-9 · Cited by 530
Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis
Briggs, A., Sculpher, M., & Buxton, M. (1994) · Health Economics · doi:10.1002/hec.4730030206 · Cited by 521
Science of urinary incontinence
Malone-Lee, J. G., Wagg, A., Mundy, A., Fry, C., Lincoln, J., & Naylor, A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91344-7 · Cited by 498
Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland
Vartiainen, E., Puska, P., Pekkanen, J., Toumilehto, J., & Jousilahti, P. (1994) · BMJ · doi:10.1136/bmj.309.6946.23 · Cited by 438
GOLDMAN, L., & COOK, E. F. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-6-825 · Cited by 381
Tunstall-Pedoe, H., Bailey, L., Chamberlain, D. A., Marsden, A. K., Ward, M. E., & Zideman, D. A. (1992) · BMJ · doi:10.1136/bmj.304.6838.1347 · Cited by 339
Bowker, T. J., Clayton, T. C., Ingham, J., McLennan, N. R., Hobson, H. L., Pyke, S. D., Schofield, B., & Wood, D. A. (1996) · Heart · doi:10.1136/hrt.75.4.334 · Cited by 305
Mant, J., & Hicks, N. (1995) · BMJ · doi:10.1136/bmj.311.7008.793 · Cited by 303
Isles, C. G., Hole, D. J., Hawthorne, V. M., & Lever, A. F. (1992) · The Lancet · doi:10.1016/0140-6736(92)90599-x · Cited by 277
Tunstall-Pedoe, H., Morrison, C., Woodward, M., Fitzpatrick, B., & Watt, G. (1996) · Circulation · doi:10.1161/01.cir.93.11.1981 · Cited by 259
Self-citationACE Inhibitor Use in Patients With Myocardial Infarction: Summary of Evidence From Clinical Trials
Latini, R., Maggioni, A. P., Flather, M., Sleight, P., & Tognoni, G. (1995) · Circulation · doi:10.1161/01.cir.92.10.3132 · Cited by 247
Control of blood pressure in Scotland: the rule of halves.
Smith, W. C., Lee, A. J., Crombie, I. K., & Tunstall-Pedoe, H. (1990) · BMJ · doi:10.1136/bmj.300.6730.981 · Cited by 195
Compliance becomes concordance: Making a change in terminology produce a change in behaviour
Mullen, P. D. (1997) · BMJ · doi:10.1136/bmj.314.7082.691 · Cited by 194
Survival of 1476 patients initially resuscitated from out of hospital cardiac arrest
Cobbe, S. M., Dalziel, K., Ford, I., & Marsden, A. K. (1996) · BMJ · doi:10.1136/bmj.312.7047.1633 · Cited by 114
Decline in ischaemic heart disease in Iceland and change in risk factor levels.
Sigfússon, N., Sigvaldason, H., Steingrímsdóttir, L., Gudmundsdottir, I. I., Stefansdottir, I., Thorsteinsson, T., & Sigurðsson, G. (1991) · BMJ · doi:10.1136/bmj.302.6789.1371 · Cited by 103
Medical management and the decline in mortality from coronary heart disease.
Beaglehole, R. (1986) · BMJ · doi:10.1136/bmj.292.6512.33 · Cited by 94
Bots, M. L., & Grobbee, D. E. (1996) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679600300302 · Cited by 76
Prevalence of coronary heart disease in Scotland: Scottish Heart Health Study.
Smith, W. C., Kenicer, M., Tunstall‐Pedoe, H., Clark, E. C., & Crombie, I. K. (1990) · Heart · doi:10.1136/hrt.64.5.295 · Cited by 75
Bots, M. L., & Grobbee, D. E. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199606000-00002 · Cited by 55
Dobson, A. J., Filipiak, B. C., Kuulasmaa, K., Beaglehole, R., Stewart, A. W., Hobbs, M., Parsons, R. W., Keil, U., Greiser, E. M., Korhonen, H. J., et al. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008666 · Cited by 31
Doliszny, K. M., Luepker, R. V., Burke, G. L., Pryor, D. B., & Blackburn, H. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90547-9 · Cited by 29
Cited by
Explaining the decrease in U.S. deaths from coronary disease, 1980–2000
Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa053935 · Cited by 2,757
Self-citationRapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010
Yang, G., Wang, Y., Zeng, Y., Gao, G. F., Liang, X., Zhou, M., Wan, X., Yu, S., Jiang, Y., Naghavi, M., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61097-1 · Cited by 1,982
Epidemiology of coronary heart disease and acute coronary syndrome
Sanchis-Gomar, F., Perez-Quilis, C., Leischik, R., & Lucia, A. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.06.33 · Cited by 1,203
Møller, A. M., Villebro, N., Pedersen, T., & Tønnesen, H. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07369-5 · Cited by 1,126
The persistence of health inequalities in modern welfare states: The explanation of a paradox
Mackenbach, J. P. (2012) · Social Science & Medicine · doi:10.1016/j.socscimed.2012.02.031 · Cited by 907
Metadata
- Authors
- Capewell, S., Morrison, C. E., & McMurray, J. J.
- Venue
- Heart
- Publisher
- BMJ
- Published
- 1999-04-01
- Volume
- 81
- Issue
- 4
- Pages
- 380-386
- ISSN
- 1355-6037 (ISSN-L)
- 1468-201X
- OpenAlex
- W2020033338
- Cited by
- 308
- References
- 37
- FWCI
- 7.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.